Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)

Zarić, Bojan; Fennell DA; Goss GD; Andric Zoran G; Bondarenko I; Ceric T; Poddubskaya E; Teofilovici F; Guo W; Ramalingam S

Results

eNauka > Results > Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)

Title:	Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels (Meeting Abstract)
Authors:	Zarić, Bojan ; Fennell DA; Goss GD; Andric Zoran G; Bondarenko I; Ceric T; Poddubskaya E; Teofilovici F; Guo W; Ramalingam S
Issue Date:	2013
Publication:	European Journal of Cancer / EJC
ISSN:	0959-8049 European Journal of Cancer / EJC Search Idenfier
Publisher:	Pergamon
Type:	Article
Collation:	vol. 49 str. S801-S801
WoS-ID:	000326843605137
URI:	https://enauka.gov.rs/handle/123456789/398387
URL:	http://www.journals.elsevier.com/european-journal-of-cancer
Metadata source:	Migrirano iz RIS podataka
M-category:	21aM21a

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.